Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the custom antibody market right now?

The size of the custom antibody market has seen swift expansion in the last few years. This market is projected to increase from $0.42 billion in 2024 to $0.47 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.6%. This considerable growth in the preceding period can be credited to several factors such as the surge in demand for custom antibodies, the widespread implementation of precision medicine, the rising incidences of chronic diseases and cancer, an uptick in research and development activities, and an increased number of clinical trials.

How fast Is the custom antibody market expected to grow, and what’s its future value?

The market size for custom antibodies is predicted to expand significantly in the coming years. By 2029, it is projected to reach a figure of $0.78 billion, with an impressive compound annual growth rate (CAGR) of 13.3%. Pushing factors for this progressive trend during the projected period include the increasing adoption of targeted immunotherapy, rising investments in biopharmaceuticals, the escalating incidence of neurodegenerative diseases, swelling demand for in vitro diagnostics (IVD) applications, along with increasing healthcare expenditure. Major anticipated trends during the forecast period comprise personalized medicine, advancements in antibody engineering technology, improvements in biotechnology and genetic engineering, broadening therapeutic applications, and progress in antibody purification techniques.

Get your custom antibody market report here!

https://www.thebusinessresearchcompany.com/report/custom-antibody-global-market-report

What are the leading drivers of growth in the custom antibody market?

The surge in preference for personalized healthcare is anticipated to fuel the expansion of the custom antibody market in the future. Personalized healthcare involves medical procedures tailored to a person’s genetic composition, living habits, and environmental influences. This increase in demand for custom medical treatment is due to progress in fields like genomics, increased accessibility of biomarker-oriented therapies, and higher consumer inclination towards personalized treatment solutions that enhance effectiveness and lessen negative side effects. Custom antibodies play a crucial role in personalized medicine by delivering specific and customized immune factors that emphasize disease identification, therapeutic targeting, and biomarker recognition for individual treatment plans. For example, in February 2024, the Food and Drug Administration (FDA) permitted Personalized Medicine Coalition, a non-profit organization based in the US, to implement 16 novel personalized treatments for patients with rare ailments in 2023, which is a significant rise from 6 in 2022. As a result, the escalating demand for personalized healthcare is stimulating the growth of the custom antibody marketplace.

What are the key segments defining the custom antibody market?

The custom antibody market covered in this report is segmented –

1) By Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Types

2) By Service: Antibody Development, Antibody Production And Purification, Antibody Fragmentation And Labeling

3) By Source: Mice, Rabbit, Other Sources

4) By Application: Oncology, Infectious Diseases, Neurology, Stem Cells, Immunology, Cardiovascular Diseases, Other Applications

5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organization, Hospitals And Clinics

Subsegments:

1) By Monoclonal Antibodies: Murine Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies, Goat Polyclonal Antibodies, Sheep Polyclonal Antibodies, Other Animal-Derived Polyclonal Antibodies

3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv), Nanobodies, Bispecific Antibodies, Antibody Fragments

4) By Other Types: Aptamers, Nanobodies (Camelid Antibodies), Hybridomas

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21162&type=smp

Who are the key players steering the development of the custom antibody market?

Major companies operating in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS

Which trends are expected to transform the custom antibody market?

Key companies in the custom antibody market are striving to innovate by incorporating cutting-edge technology like artificial intelligence (AI) in order to improve antibody discovery and specificity, and to expedite the developmental processes. AI is being utilized in this sector for its capabilities to enhance antigen selection, predict antibody-antigen bonding, and streamline the screening process of candidates using machine learning which in turn leads to quicker and cost-efficient biopharmaceutical research. For example, a US-based biotech firm, Archon Biosciences Inc., which started with a funding of $20 million in October 2024, aims to develop antibody cages designed computationally for the customization of pre-existing antibodies for therapeutic uses. Their unique technology constructs antibodies into caged structures and thus permits alterations to their traits without changing their fundamental structures. This breakthrough is expected to boost antibody affinity towards therapeutic targets, minimize off-target interactions, and enhance both effectiveness and safety.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21162

Which regions are most influential in expanding the custom antibody market?

North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom antibody market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Yellow Fever Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Influenza A Virus Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025

https://thebusinessresearchcompany.com/report/lateral-flow-immunoassay-based-rapid-test-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: